Form 4: BioAtla Executive's Tax-Related Stock Withholding

BioAtla's Chief Accounting Officer, Christian Vasquez, had 1,566 shares withheld by the company to cover tax obligations from restricted stock unit vesting.

Summary

• Christian Vasquez, BioAtla, Inc.'s Chief Accounting Officer, Corporate Controller, and Secretary, reported a transaction on August 31, 2025.
• The transaction involved the disposition of 1,566 shares of BioAtla Common Stock at a price of $0.4555 per share.
• This disposition was not a sale by Mr. Vasquez but represented shares withheld by BioAtla to satisfy income tax and withholding obligations related to the vesting and net settlement of previously reported restricted stock units.
• Following this transaction, Mr. Vasquez beneficially owns 283,564 shares of BioAtla Common Stock directly.

Sentiment

Score: 5

Explanation: The filing reports a routine, non-discretionary tax withholding transaction related to the vesting of restricted stock units. This type of insider transaction is neutral in sentiment as it does not reflect a discretionary buy or sell decision by the executive, nor does it provide new information about the company's operational or financial performance.

Positives

• The transaction is a routine tax withholding event, not a discretionary sale by the insider, which typically indicates a neutral stance rather than a negative one.
• The vesting of restricted stock units implies that previously granted compensation to the executive has matured, reflecting continued employment and performance.

Negatives

• No negative implications are directly apparent from this routine tax withholding transaction.

Risks

• No specific risks are mentioned or implied by this routine Form 4 filing.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or operations.

Management Comments

• This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units.

Industry Context

This Form 4 filing reports a standard insider transaction related to executive compensation and tax obligations. Such transactions are common across all industries when restricted stock units or similar equity awards vest for corporate executives, and do not typically reflect specific industry trends or competitive positioning.

Comparison to Industry Standards

• This is a routine tax withholding transaction for an executive's equity compensation. It aligns with standard practices for managing restricted stock unit vesting and associated tax liabilities in publicly traded companies across various sectors, including biotechnology. There are no specific comparable companies, projects, or results to detail as this is an administrative event.

Stakeholder Impact

• Shareholders: Minimal impact, as this is a routine administrative transaction related to executive compensation and not a discretionary sale or purchase.
• Employees: No direct impact on general employees.
• Customers: No direct impact.
• Suppliers: No direct impact.
• Creditors: No direct impact.

Next Steps

• No specific future actions, events, or milestones are mentioned in this filing.

Key Dates

Keywords

BioAtla, BCAB, Christian Vasquez, Form 4, Insider Transaction, Stock Withholding, Restricted Stock Units, RSU Vesting, Tax Obligations, Corporate Controller, Chief Accounting Officer